Successful treatment of refractory advanced nasal NK/T cell lymphoma with unrelated cord blood stem cell transplantation incorporating focal irradiation
- PMID: 19949902
- DOI: 10.1007/s12185-009-0453-8
Successful treatment of refractory advanced nasal NK/T cell lymphoma with unrelated cord blood stem cell transplantation incorporating focal irradiation
Abstract
Nasal natural killer (NK)/T cell lymphoma is a rare disease with a poor prognosis. We report the case of a 52-year-old woman with progressive advanced nasal NK/T cell lymphoma, with local invasiveness and bone marrow involvement, who was successfully treated with unrelated cord blood transplantation (UCBT). The patient was initially refractory to conventional chemotherapy. She was therefore treated with local irradiation, which induced a partial response. The patient then underwent UCBT using a conditioning regimen consisting of cyclophosphamide and total body irradiation. Acute graft-versus-host disease involving the skin was observed, but it was well controlled without systemic administration of corticosteroids. The patient remained in complete remission for 18 months after UCBT. Although the observation period has been relatively short and longer follow-up is needed, our observations suggest that incorporating focal irradiation to conditioning regimen for local control might be an effective treatment option for advanced nasal NK/T cell lymphoma in the setting of UCBT.
Similar articles
-
Successful treatment of advanced extranodal NK/T cell lymphoma with unrelated cord blood transplantation.Tohoku J Exp Med. 2007 Apr;211(4):395-9. doi: 10.1620/tjem.211.395. Tohoku J Exp Med. 2007. PMID: 17409680
-
Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report.J Med Case Rep. 2020 Mar 17;14(1):43. doi: 10.1186/s13256-020-02363-3. J Med Case Rep. 2020. PMID: 32183896 Free PMC article.
-
Successful treatment of relapsed blastic natural killer cell lymphoma with unrelated cord blood transplantation.Bone Marrow Transplant. 2002 Jul;30(1):41-4. doi: 10.1038/sj.bmt.1703597. Bone Marrow Transplant. 2002. PMID: 12105776 Review.
-
Mediastinal single nodal relapse of a nasal NK/T cell lymphoma.Korean J Intern Med. 2007 Sep;22(3):201-5. doi: 10.3904/kjim.2007.22.3.201. Korean J Intern Med. 2007. PMID: 17939339 Free PMC article.
-
Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type.Br J Haematol. 2009 Oct;147(1):13-21. doi: 10.1111/j.1365-2141.2009.07802.x. Epub 2009 Jul 7. Br J Haematol. 2009. PMID: 19604234 Review.
Cited by
-
Hematopoietic stem cell transplantation in natural killer cell lymphoma and leukemia.Int J Hematol. 2010 Dec;92(5):702-7. doi: 10.1007/s12185-010-0724-4. Epub 2010 Nov 25. Int J Hematol. 2010. PMID: 21107769 Review.
-
Treatment outcome of radiotherapy alone versus radiochemotherapy in IE/IIE extranodal nasal-type natural killer/T cell lymphoma: a meta-analysis.PLoS One. 2014 Sep 3;9(9):e106577. doi: 10.1371/journal.pone.0106577. eCollection 2014. PLoS One. 2014. PMID: 25184382 Free PMC article.
-
Allogeneic Hematopoietic Stem Cell Transplantation in Extranodal Natural Killer/T-cell Lymphoma.Turk J Haematol. 2021 Jun 1;38(2):126-137. doi: 10.4274/tjh.galenos.2021.2020.0438. Epub 2021 Feb 4. Turk J Haematol. 2021. PMID: 33535731 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical